← All stocks

Tonix Pharmaceuticals Holding Corp.

TNXP Net buying
CIK 0001430306 #3890 in the set updated 17 Sep 2026
Bought (12 mo)
$458.76K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$458.76K
+$458.76K against sales at will

By person

9 insiders · 7 transactions
1.0×

Seth Lederman holds only 1.0 times base salary in stock. $703.40K of shares against $702.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Seth Lederman last reported holding, valued at $13.79, the price Common Stock, $0.001 par value was last bought or sold at on the open market here, on 27 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
LEDERMAN SETH
Chief Executive Officer
$372.98K (4)
+$372.98K
51,008
$703.40K
+154.9%
Stillwell Richard Newcomb
Director
$58.25K (1)
+$58.25K
5,000
$68.95K
Taylor Carolyn E.
Director
$14.93K (1)
+$14.93K
1,833
$25.28K
BAGGER RICHARD H
Director
$12.60K (1)
+$12.60K
1,000
$13.79K
SAENGER BRADLEY
Chief Financial Officer
2,154
$29.70K
+207.3%
Treco James
Director
250
$3.45K
Bell Margaret Smith
Director
0
$0.00
−100.0%
MORRIS JESSICA EDGAR
Chief Operating Officer
0
$0.00
−100.0%
SULLIVAN GREGORY M
Chief Medical Officer
0
$0.00

No percentages here. This company's share count has moved by a factor of 29.0 over the window, from 6,434,881 to 186,894,225 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,453
History held since 14 Sep 2016